412
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Increased absorption of mangiferin in the gastrointestinal tract and its mechanism of action by absorption enhancers in rats

, , , , , & show all
Pages 1408-1413 | Received 30 Mar 2012, Accepted 13 Jun 2012, Published online: 21 Jul 2012

References

  • Aritomi M, Kawasaki T. (1969). A new xanthone C-glucoside, position isomer of mangiferin, from Anemarrhena asphodeloides Bunge. Tetrahedron Lett, 12:941–944.
  • Bairy I, Reeja S, Siddharth, Rao PS, Bhat M, Shivananda PG. (2002). Evaluation of antibacterial activity of Mangifera indica on anaerobic dental microglora based on in vivo studies. Indian J Pathol Microbiol, 45:307–310.
  • Yoshikawa M, Ninomiya K, Shimoda H, Nishida N, Matsuda H. (2002). Hepatoprotective and antioxidative properties of Salacia reticulata: preventive effects of phenolic constituents on CCl4-induced liver injury in mice. Biol Pharm Bull, 25:72–76.
  • Sato T, Kawamoto A, Tamura A, Tatsumi Y, Fujii T. (1992). Mechanism of antioxidant action of pueraria glycoside (PG)-1 (an isoflavonoid) and mangiferin (a xanthonoid). Chem Pharm Bull, 40:721–724.
  • Makare N, Bodhankar S, Rangari V. (2001). Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacol, 78:133–137.
  • Yoshimi N, Matsunaga K, Katayama M, Yamada Y, Kuno T, Qiao Z et al. (2001). The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats. Cancer Lett, 163:163–170.
  • Rivera DG, Balmaseda IH, León AA, Hernández BC, Montiel LM, Garrido GG et al. (2006). Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin. J Pharm Pharmacol, 58:385–392.
  • Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K et al. (1998). New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull, 21:1389–1390.
  • Kuhnle G, Spencer JP, Chowrimootoo G, Schroeter H, Debnam ES, Srai SK et al. (2000). Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun, 272:212–217.
  • Sanugul K, Akao T, Li Y, Kakiuchi N, Nakamura N, Hattori M. (2005). Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond. Biol Pharm Bull, 28:1672–1678.
  • Han D, Chen C, Zhang C, Zhang Y, Tang X. (2010). Determination of mangiferin in rat plasma by liquid–liquid extraction with UPLC-MS/MS. J Pharm Biomed Anal, 51:260–263.
  • Varma MV, Panchagnula R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci, 25:445–453.
  • Sinko PJ, Lee YH, Makhey V, Leesman GD, Sutyak JP, Yu H et al. (1999). Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT). Pharm Res, 16:527–533.
  • Scott Swenson E, Curatolo WJ. (1992). (C) Means to enhance penetration::(2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv Drug Deliv Rev, 8, 39–92.
  • Thanou M, Verhoef JC, Nihot MT, Verheijden JH, Junginger HE. (2001). Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P. Pharm Res, 18:1638–1641.
  • Luessen HL, de Leeuw BJ, Langemeÿer MW, de Boer AB, Verhoef JC, Junginger HE. (1996). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res, 13:1668–1672.
  • Shin HS, Bae SK, Lee MG. (2006). Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects. Int J Pharm, 320:64–70.
  • Dintaman JM, Silverman JA. (1999). Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res, 16:1550–1556.
  • Gullikson GW, Cline WS, Lorenzsonn V, Benz L, Olsen WA, Bass P. (1977). Effects of anionic surfactants on hamster small intestinal membrane structure and function: relationship to surface activity. Gastroenterology, 73:501–511.
  • Fasano A, Budillon G, Guandalini S, Cuomo R, Parrilli G, Cangiotti AM et al. (1990). Bile acids reversible effects on small intestinal permeability. An in vitro study in the rabbit. Dig Dis Sci, 35:801–808.
  • Lueßen HL, Lehr C-M, Rentel C-O, Noach ABJ, de Boer AG, Verhoef JC, et al. (1994). Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release, 29, 329–338.
  • Walsh C. (1980). Flavin coenzymes: at the crossroads of biological redox chemistry. Accounts Chem Res, 13, 148–155.
  • Davis SS. (2005). Formulation strategies for absorption windows. Drug Discov Today, 10:249–257.
  • Vasir JK, Tambwekar K, Garg S. (2003). Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm, 255:13–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.